Is Nanosonics Limited a good investment? Nanosonics Limited (NAN.AX) is currently trading at 3.35 AUD. Market analysts have a consensus price target of 4.30 AUD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 47.57. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Nanosonics Limited is expected to release its next earnings report on Aug. 24, 2026. The market consensus estimate for Forward EPS is 0.07.
No, it does not currently pay a dividend.
Nanosonics Limited is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be Aug. 24, 2026. The company currently has a trailing EPS of 0.07.
Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabilities to connect trophon 2 with hospital IT systems; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Community Discussion